← Back to Search

Brief Intervention for Alcohol Use in HIV Prevention

N/A

Waitlist Available

Led By Paul A. Shuper, PhD

Research Sponsored by Centre for Addiction and Mental Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must be aged 18 years or older

Participants must have been prescribed PrEP for at least 3 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up six-month follow-up period

Awards & highlights

No Placebo-Only Group

Summary

This trial will explore if a brief intervention on reducing alcohol use & substance use can help people on HIV PrEP treatment.

Who is the study for?

This trial is for men aged 18 or older who identify as gay, bisexual, or have sex with other men and are patients at TGH or MLMC. They must be on PrEP for HIV prevention for at least 3 months and drink alcohol at levels considered hazardous.

What is being tested?

The study tests if a brief intervention focused on reducing alcohol use can be practical, well-received, and effective among individuals using HIV pre-exposure prophylaxis (PrEP) treatment.

What are the potential side effects?

Since the intervention involves counseling rather than medication, typical drug side effects aren't expected. However, participants may experience emotional discomfort discussing personal habits like drinking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been on PrEP for at least 3 months.

Select...

I am a man who identifies as gay, bisexual, or has sex with other men.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ six-month follow-up period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~six-month follow-up period

This trial's timeline: 3 weeks for screening, Varies for treatment, and six-month follow-up period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Alcohol consumption: Alcohol Use Disorders Identification Test (AUDIT)

Alcohol consumption: Greatest number of drinks on one day in the last 3 months

Alcohol consumption: Number of drinks consumed in a typical week

+4 more

Secondary study objectives

Condomless sex

PrEP adherence: 7-day ACTG-based measure

PrEP adherence: Past month visual analog scale (VAS)

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Alcohol-focused brief interventionExperimental Treatment1 Intervention

Intervention arm participants will be provided with an electronically-delivered, personalized drinking feedback report that compares their drinking with other Canadian males of the same age. This report also includes other relevant feedback, including an assessment of severity of alcohol use, and it provides recommendations for safe levels of alcohol consumption.

Group II: Treatment as usualActive Control1 Intervention

Treatment as usual (TAU) participants will not receive the intervention.

0 / 3Eligibility criteria met